Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

Group 1: Company Development and Strategy - The new controlling shareholder, Iron Investment Group, focuses on supporting major infrastructure construction in Shandong Province, particularly high-speed rail projects [1] - The company aims to develop three key industries: new energy, new materials, and new equipment, positioning itself as an important platform for Iron Investment Group's new equipment industry [1] - The company will combine internal growth with external mergers and acquisitions, leveraging group synergies for project cooperation and investment [1] Group 2: Market Expansion and Product Development - The company is exploring opportunities in the industrial products, high-end equipment, and new materials sectors, but currently has no plans to transition into artificial intelligence [1] - The subsidiary, Changzhou Jinniu Grinding, focuses on the R&D, production, and sales of abrasive products, primarily large roll products, and plans to expand its overseas market presence through strategic partnerships [2] Group 3: Domestic Market and Competitive Advantage - The company sees potential for growth in the domestic market and plans to leverage its competitive advantages gained from recent internal improvements, focusing on cost leadership and scale effects [3] - Efforts will include enhancing team building, broadening sales channels, and optimizing resource allocation through technological innovation and product upgrades [3] Group 4: Value Management and Investor Relations - The company emphasizes value management, maintaining a focus on sustainable development and consistent cash dividends to reward investors [4] - It aims to improve operational performance and profitability while enhancing communication with investors to convey company value [4] Group 5: Mergers and Acquisitions - The company will consider business synergy, team compatibility, and industry prospects when selecting acquisition projects, with a cautious approach to evaluating risks in the current economic environment [5] - It will actively research business opportunities in advanced manufacturing while ensuring risk control [5]

Overview - The demand for CBN (Cubic Boron Nitride) grinding wheels is increasing due to the high-end and intelligent development of China's manufacturing industry, particularly in aerospace, automotive manufacturing, and emerging industries like new energy vehicles and 5G communication [1][10] - The market size of China's CBN grinding wheel industry is projected to reach 893 million yuan in 2024, with a year-on-year growth of 4.44% [1][10] Industry Background - China's manufacturing industry is rapidly growing, with a reported industrial added value of 40.5442 trillion yuan in 2024, a 5.7% increase from the previous year, and manufacturing growth at 6.1% [5] - The expansion of high-end manufacturing sectors is driving the demand for CBN grinding wheels, supported by increased R&D investments from universities and research institutions in collaboration with CBN wheel manufacturers [5] Industry Chain - The CBN grinding wheel industry consists of upstream raw material suppliers (like cubic boron nitride), binder suppliers (metal, resin, ceramic powders), and production equipment suppliers [8] Competitive Landscape - The CBN grinding wheel market is becoming increasingly competitive, with numerous companies entering the space. Key players include Anhui Weiming Wear-resistant Materials Co., Ltd., Jiangsu Saiyang Precision Technology Co., Ltd., and others [12] - As of April 22, 2025, Anhui Weiming leads in patent applications for CBN grinding wheels with 23 applications, followed closely by Jiangsu Saiyang with 22 applications [12] Company Analysis - **Kunshan Xinlun Superhard Tools Co., Ltd.**: A high-tech enterprise focusing on ceramic CBN superhard tools, widely used in various industries including automotive and aerospace, with products exported to high-end markets [14] - **Jiangxi Zhenxin Grinding Wheel Co., Ltd.**: Specializes in resin-bonded tools, leading in sales of double-sided resin wheels in Jiangxi, with applications in automotive manufacturing and other sectors [16] Development Trends - Future advancements in CBN grinding wheels will focus on improving grinding efficiency and precision through enhanced material formulations and manufacturing processes [18] - The industry is expected to move towards green production practices, developing eco-friendly binders and energy-saving production methods to reduce waste and emissions [18]

关于南京三超新材料股份有限公司 申请向特定对象发行股票审核问询函的回复 天衡专字 (2023) 00076 号 天衡会计师事务所（特殊普通合伙） 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查询 " 2-1 关于南京三超新材料股份有限公司 申请向特定对象发行股票审核问询函的回复 天衡专字(2023)00076 号 深圳证券交易所: 根据贵所于 2022年 12月 8日出具的《关于南京三超新材料股份有限公司申请向 特定对象发行股票的审核问询函》(审核函(2022 ) 020282 号)(以下简称"问询 函"),天衡会计师事务所(特殊普通合伙)(以下简称"会计师")作为南京三超新材 料股份有限公司(以下简称"公司"、"三超新材"或"发行人")申请向特定对象发行股 票的会计师,对问询函中提出的需由会计师进行核查的有关问题逐条回复如下: 除另有说明外,本问询函回复使用的简称与《南京三超新材料股份有限公司 2022 年度向特定对象发行 A 股股票募集 ...